Market revenue in 2023 | USD 1,057.5 million |
Market revenue in 2030 | USD 2,171.1 million |
Growth rate | 10.8% (CAGR from 2023 to 2030) |
Largest segment | Anti-infective |
Fastest growing segment | Endocrinology |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Anti-Infective, Endocrinology, Hydration Therapy, Chemotherapy, Enteral Nutrition, Parenteral Nutrition, Specialty Pharmaceuticals |
Key market players worldwide | CVS Group PLC, Walgreens Boots Alliance Inc, UnitedHealth Group Inc, BrightSpring Health Services Inc, Fresenius Medical Care AG, ICU Medical Inc, B. Braun Medical, Baxter International Inc, BD, Smiths Group PLC, Terumo Corp, Caesarea Medical Electronics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to home infusion therapy market will help companies and investors design strategic landscapes.
Anti-infective was the largest segment with a revenue share of 26.76% in 2023. Horizon Databook has segmented the India home infusion therapy market based on anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals covering the revenue growth of each sub-segment from 2018 to 2030.
According to World Bank Group, the country’s population aged 65 & above accounted for nearly 6.0% of the total population in 2017 and around 6.4% in 2019. Rise in geriatric population is anticipated to increase the demand for long term and home care services, thereby fueling the market growth.
The home care & hospice industry is still in nascent stage in India, but it is anticipated to grow lucratively over the forecast period. This can be attributed to various initiatives undertaken by market players to improve quality of homecare in the country.
For instance, HealthCare at Home introduced home ICU services, while Apollo Hospitals offers low priced homecare services to its patients. Furthermore, startups such as Portea, Zoctr, Critical Care Unified, Nightingales, and Care24 are transforming the Indian home healthcare market. Investments in home healthcare market by organizations such as Sequoia Capital and Accel Partners are also anticipated to boost the homecare market in the country, thereby fueling the growth of home infusion therapy market.
Horizon Databook provides a detailed overview of country-level data and insights on the India home infusion therapy market , including forecasts for subscribers. This country databook contains high-level insights into India home infusion therapy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account